Engineering topics

Yi, Xiaoyan

Publications and source records attributed to Yi, Xiaoyan.

5 records

DOE OSTI2026

Multi-omics data resource: Data package 22 (Pck022)

In type 1 diabetes (T1D), autoimmune response and inflammation cause the death of pancreatic ß cells, leading to the body’s inability to produce insulin and maintain glucose homeostasis. This process is at least in part mediated by pro-inflammatory cytokines, such as interferon (IFN)a, IFN?, interleukin (IL)-1ß, and tumor necrosis factor (TNF)a, which induce ß-cell dysfunction and apoptosis. A deep understanding of the ß-cell signaling and regulatory networks induced by these cytokines could lead to the identification of therapeutic targets to prevent T1D development. To study cytokine-mediated islets/ß-cell signaling and regulatory networks, a variety of omics experiments have been conducted, including transcriptomics, epigenomics (DNA methylation, UMI-4C, ATAC-seq & ChIP-seq), proteomics (bottom-up, top-down, post-translational modification analysis), lipidomics, and metabolomics. The combination of these datasets can be instrumental in identifying signaling components and regulatory factors involved in ß-cell stress/death. Here, we aggregated these multiple omics datasets into a centralized location, providing a quality-controlled and statistically rigorous resource for investigators seeking to holistically study ß-cell regulation by pro-inflammatory cytokines. The data package consists of isolated pancreatic islets from adult male C57BL6/J mice treated with IL-1β, IFNγ or IL-1β + IFNγ for 6 h and submitted for scRNA-seq. This study focused on understanding the heterogeneity of the cytokine-mediated response. Data contributors: Jennifer S Stancill & John A Corbett: Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA Data repository: GSE156175 Publication: 10.26508/lsa.202000949

Sarkar, Soumyadeep [Pacific Northwest National Lab↗

DOE OSTI2026

Multi-omics data resource: Data package 23 (Pck023)

The data package consists of isolated pancreatic islets from adult male C57BL6/J mice treated with IL-1β + IFNγ, IL-1β + IFNγ + NMMA, or NMMA alone for 18 h and submitted for scRNA-seq. This study focused on the cell-type-specific effects of nitric oxide signaling in islets and characterized the heterogeneity of responses. Data contributors: Jennifer S Stancill & John A Corbett: Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA Data repository: GSE183010 Publication: 10.1093/function/zqab063

Sarkar, Soumyadeep [Pacific Northwest National Lab↗

DOE OSTI2026

Multi-omics data resource: Data package 24 (Pck024)

The data package consists of isolated pancreatic islets from 3 human donors treated with IL-1β, IFNγ or IL-1β + IFNγ for 6 h and IL-1β, IFNγ, IL-1β + IFNγ, IL-1β + IFNγ + NMMA or NMMA for 18 h and submitted for scRNA-seq. This study examines cytokine-stimulated changes in gene expression in human islets using single-cell RNA sequencing. Data contributors: Jennifer S Stancill & John A Corbett: Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA Data repository: GSE251730 Publication: 10.1093/function/zqae015

Sarkar, Soumyadeep [Pacific Northwest National Lab↗

DOE OSTI2026

Multi-omics data resource: Data package 25 (Pck025)

This data package comprises omics datasets from human pancreatic islets treated with IL-1β + IFNγ or with estrogen (E2) for 18 h. Two RNA-seq datasets are available: the first is a discovery dataset involving human islets treated with or without IL-1β + IFNγ for 18 hours; the second is a validation dataset, where human islets are treated with or without IL-1β + IFNγ or E2 for 18 hours. DIA proteomic analysis was performed on the same validation dataset samples. Data contributors: Kiersten L. Webster, Sarah Tersey & Raghavendra G. Mirmir: Kovler Diabetes Center and Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA. Soumyadeep Sarkar, Raghavendra Mirmira, Ernesto S. Nakayasu: Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99354, USA. Data repository: RNA-seq: GSE310965 Proteomics: MSV000101892 Publication: PMID 41279069

Sarkar, Soumyadeep [Pacific Northwest National Lab↗

DOE OSTI2024

Inhibition of the eukaryotic initiation factor-2α kinase PERK decreases risk of autoimmune diabetes in mice

Preventing the onset of autoimmune type 1 diabetes (T1D) is feasible through pharmacological interventions that target molecular stress–responsive mechanisms. Cellular stresses, such as nutrient deficiency, viral infection, or unfolded proteins, trigger the integrated stress response (ISR), which curtails protein synthesis by phosphorylating eukaryotic translation initiation factor-2α (eIF2α). In T1D, maladaptive unfolded protein response (UPR) in insulin-producing β cells renders these cells susceptible to autoimmunity. We found that inhibition of the eIF2α kinase PKR-like ER kinase (PERK), a common component of the UPR and ISR, reversed the mRNA translation block in stressed human islets and delayed the onset of diabetes, reduced islet inflammation, and preserved β cell mass in T1D-susceptible mice. Single-cell RNA-Seq of islets from PERK-inhibited mice showed reductions in the UPR and PERK signaling pathways and alterations in antigen-processing and presentation pathways in β cells. Spatial proteomics of islets from these mice showed an increase in the immune checkpoint protein programmed death-ligand 1 (PD-L1) in β cells. Golgi membrane protein 1, whose levels increased following PERK inhibition in human islets and EndoC-βH1 human β cells, interacted with and stabilized PD-L1. Collectively, our studies show that PERK activity enhances β cell immunogenicity and that inhibition of PERK may offer a strategy for preventing or delaying the development of T1D.

Research & Experimental Medicine↗